RE:Trog IV push dataTwo days, two press releases after two months with no press releases. Maybe they are learning finally how to build some momentum and anticipation among investors.
This is old news but the new information is the PDUFA date of 10/3. It looks like Bloomberg had the early Februray date wrong and got the acceptence of their application by the FDA mixed up withthe PDUFA date.
I think it should be mentioned that the IV Push version will be approved about 4 and a half years after the original version of Trogarzo when Taimed and TH were saying at the time of the first approval they would have a new version of Trogarzo ready to go about a year after the initial approval. Clearly, there were issues in developing this version that were not anticipated originally but Taiimed likely gets the blame for that.
I suspect the new version will help sales a little but the biggest issue now for Trogarzo is competition. Had they been able to develop this better version of the drug in a more timely fashion, it may have helped them lock up more patients before the competition arrived,